N-[4-amino-5-[[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]ethyl]piperidin-4-yl]iminomethyl]-2-(2-hydroxypropan-2-yl)phenyl]-6-(trifluoromethyl)pyridine-2-carboxamide

C41H46F3N9O6 — CID 170190838

IUPACN-[4-amino-5-[[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]ethyl]piperidin-4-yl]iminomethyl]-2-(2-hydroxypropan-2-yl)phenyl]-6-(trifluoromethyl)pyridine-2-carboxamide
SMILESCC(C)(O)c1cc(N)c(/C=N/C2CCN(CCN3CCN(c4ccc5c(c4)C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)CC2)cc1NC(=O)c1cccc(C(F)(F)F)n1
InChIInChI=1S/C41H46F3N9O6/c1-40(2,59)29-22-30(45)24(20-32(29)48-36(55)31-4-3-5-34(47-31)41(42,43)44)23-46-25-10-12-50(13-11-25)14-15-51-16-18-52(19-17-51)26-6-7-27-28(21-26)39(58)53(38(27)57)33-8-9-35(54)49-37(33)56/h3-7,20-23,25,33,59H,8-19,45H2,1-2H3,(H,48,55)(H,49,54,56)/b46-23+
InChIKeyUOZQICXROZDZFX-ZBIWZBSJSA-N
MW817.87 g/mol
LogP3.27
Rot. Bonds10

About N-[4-amino-5-[[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]ethyl]piperidin-4-yl]iminomethyl]-2-(2-hydroxypropan-2-yl)phenyl]-6-(trifluoromethyl)pyridine-2-carboxamide

N-[4-amino-5-[[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]ethyl]piperidin-4-yl]iminomethyl]-2-(2-hydroxypropan-2-yl)phenyl]-6-(trifluoromethyl)pyridine-2-carboxamide (PubChem CID 170190838) has the molecular formula C41H46F3N9O6 and a molecular weight of 817.87 g/mol. Its IUPAC name is N-[4-amino-5-[[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]ethyl]piperidin-4-yl]iminomethyl]-2-(2-hydroxypropan-2-yl)phenyl]-6-(trifluoromethyl)pyridine-2-carboxamide.

Molecular Properties

Compound NameN-[4-amino-5-[[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]ethyl]piperidin-4-yl]iminomethyl]-2-(2-hydroxypropan-2-yl)phenyl]-6-(trifluoromethyl)pyridine-2-carboxamide
PubChem CID170190838
Molecular FormulaC41H46F3N9O6
Molecular Weight817.87 g/mol
Exact Mass817.35
IUPAC NameN-[4-amino-5-[[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]ethyl]piperidin-4-yl]iminomethyl]-2-(2-hydroxypropan-2-yl)phenyl]-6-(trifluoromethyl)pyridine-2-carboxamide
SMILESCC(C)(O)c1cc(N)c(/C=N/C2CCN(CCN3CCN(c4ccc5c(c4)C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)CC2)cc1NC(=O)c1cccc(C(F)(F)F)n1
InChIInChI=1S/C41H46F3N9O6/c1-40(2,59)29-22-30(45)24(20-32(29)48-36(55)31-4-3-5-34(47-31)41(42,43)44)23-46-25-10-12-50(13-11-25)14-15-51-16-18-52(19-17-51)26-6-7-27-28(21-26)39(58)53(38(27)57)33-8-9-35(54)49-37(33)56/h3-7,20-23,25,33,59H,8-19,45H2,1-2H3,(H,48,55)(H,49,54,56)/b46-23+
InChIKeyUOZQICXROZDZFX-ZBIWZBSJSA-N
XLogP3.27
TPSA193.87 Ų
H-Bond Donors4
H-Bond Acceptors12
Rotatable Bonds10
Heavy Atoms59
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500817.87
LogP ≤ 53.27
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aniline', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze N-[4-amino-5-[[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]ethyl]piperidin-4-yl]iminomethyl]-2-(2-hydroxypropan-2-yl)phenyl]-6-(trifluoromethyl)pyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[4-amino-5-[[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]ethyl]piperidin-4-yl]iminomethyl]-2-(2-hydroxypropan-2-yl)phenyl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The IUPAC name of N-[4-amino-5-[[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]ethyl]piperidin-4-yl]iminomethyl]-2-(2-hydroxypropan-2-yl)phenyl]-6-(trifluoromethyl)pyridine-2-carboxamide (CID 170190838) is N-[4-amino-5-[[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]ethyl]piperidin-4-yl]iminomethyl]-2-(2-hydroxypropan-2-yl)phenyl]-6-(trifluoromethyl)pyridine-2-carboxamide.
What is the SMILES notation for N-[4-amino-5-[[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]ethyl]piperidin-4-yl]iminomethyl]-2-(2-hydroxypropan-2-yl)phenyl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The canonical SMILES for N-[4-amino-5-[[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]ethyl]piperidin-4-yl]iminomethyl]-2-(2-hydroxypropan-2-yl)phenyl]-6-(trifluoromethyl)pyridine-2-carboxamide is CC(C)(O)c1cc(N)c(/C=N/C2CCN(CCN3CCN(c4ccc5c(c4)C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)CC2)cc1NC(=O)c1cccc(C(F)(F)F)n1.
What is the InChIKey of N-[4-amino-5-[[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]ethyl]piperidin-4-yl]iminomethyl]-2-(2-hydroxypropan-2-yl)phenyl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The InChIKey is UOZQICXROZDZFX-ZBIWZBSJSA-N. The full InChI is InChI=1S/C41H46F3N9O6/c1-40(2,59)29-22-30(45)24(20-32(29)48-36(55)31-4-3-5-34(47-31)41(42,43)44)23-46-25-10-12-50(13-11-25)14-15-51-16-18-52(19-17-51)26-6-7-27-28(21-26)39(58)53(38(27)57)33-8-9-35(54)49-37(33)56/h3-7,20-23,25,33,59H,8-19,45H2,1-2H3,(H,48,55)(H,49,54,56)/b46-23+.
What are the key properties of N-[4-amino-5-[[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]ethyl]piperidin-4-yl]iminomethyl]-2-(2-hydroxypropan-2-yl)phenyl]-6-(trifluoromethyl)pyridine-2-carboxamide?
N-[4-amino-5-[[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]ethyl]piperidin-4-yl]iminomethyl]-2-(2-hydroxypropan-2-yl)phenyl]-6-(trifluoromethyl)pyridine-2-carboxamide has a molecular weight of 817.87 g/mol, XLogP of 3.27, 10 rotatable bonds, 4 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-amino-5-[[1-[2-[4-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperazin-1-yl]ethyl]piperidin-4-yl]iminomethyl]-2-(2-hydroxypropan-2-yl)phenyl]-6-(trifluoromethyl)pyridine-2-carboxamide is sourced from PubChem (CID 170190838), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).